Recombinant Human NUCB2 Protein，His

NUCB2, or Nucleobindin-2, is a calcium-binding protein that plays a significant role in various physiological processes, including energy metabolism, neuroprotection, and regulation of appetite by functioning as a precursor to neuropeptide orexin. Research on NUCB2 has garnered attention due to its involvement in metabolic diseases, neurodegenerative disorders, and obesity. Evidence suggests that NUCB2 influences insulin secretion and glucose homeostasis, making it a potential target for therapeutic interventions in type 2 diabetes. Moreover, its neuroprotective properties indicate a promising role in combating conditions like Alzheimer's disease, where it may help mitigate neuronal damage. As NUCB2 is processed into biologically active peptides, the recombinant expression of NUCB2 protein has become pivotal in studies seeking to elucidate its structure-function relationships and therapeutic potential. Characterizing NUCB2 through recombinant protein techniques enables researchers to investigate its biological mechanisms in detail and explore its applications in drug development, particularly for conditions linked to metabolic dysregulation and neurodegeneration. The ongoing research into NUCB2 not only enhances our understanding of its cellular roles but also opens up new avenues for innovative treatments targeting metabolic and neurodegenerative diseases.